End-to-end antibody development partner
Progressing your antibody to the clinic is challenging, but we understand the hurdles. We offer a complete end-to-end service from antigen design to cell line development.
We work in partnership as an extension of your team to deliver the project requirements while also considering long term goals of manufacturability and commercialization.
“One of the humanized antibodies you designed for us has excellent function and has undergone GMP production with a highly experienced CMO. According to this CMO, the antibody is the poster child for the best producing and most well-behaved antibody they have seen to date, and it will serve as the benchmark to match or exceed for their future projects.
My and OncoResponse’s hats are off to you for a job well done.”
https://fusionantibodies.com/wp-content/uploads/c54b2ef3-04c8-4587-a379-357a52baeae4.png
536
1024
Naomi Nelson
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg
Naomi Nelson2023-03-30 15:17:172023-04-20 14:49:38BIO International 2023
https://fusionantibodies.com/wp-content/uploads/fusionantibodies017-2-scaled.jpg
1707
2560
Naomi Nelson
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg
Naomi Nelson2023-02-10 12:30:072023-03-06 11:49:18R&D update: Mammalian Display service
https://fusionantibodies.com/wp-content/uploads/Long-road-to-the-clinic.png
329
649
Carolyn Lowry
/wp-content/uploads/2022/01/fusion-antibodies-logo.svg
Carolyn Lowry2023-02-02 16:20:452023-03-06 11:53:58Overcoming obstacles on the path to the clinic
info@fusionantibodies.com
+44 (0)28 9043 2800
Investor and Media
+44 (0)20 7933 8780
fusion@walbrookpr.com
Fusion Antibodies PLC, Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast BT17 0QL
